{"transactions":[{"id":2763478,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2021-04-01T22:54:16.000Z","date":"2021-03-31","kind":"tax_withholding","acquired":false,"shares":159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated"}],"balance_after":17776,"source":{"system":"sec-edgar","filing":"0001367644-21-000055","document":"wf-form4_161731759604526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000055/wf-form4_161731759604526.xml","form_type":"4"}},{"id":2829175,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-26T22:16:39.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":12835,"price":93.49,"value":1199944.15,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":12835,"derivative":{"exercise_price":93.49,"expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":12835},"source":{"system":"sec-edgar","filing":"0001367644-21-000045","document":"wf-form4_161437776370492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000045/wf-form4_161437776370492.xml","form_type":"4"}},{"id":2829174,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2021-02-26T22:16:39.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":17935,"source":{"system":"sec-edgar","filing":"0001367644-21-000045","document":"wf-form4_161437776370492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000045/wf-form4_161437776370492.xml","form_type":"4"}},{"id":2829173,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2021-02-26T22:16:39.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":18220,"source":{"system":"sec-edgar","filing":"0001367644-21-000045","document":"wf-form4_161437776370492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000045/wf-form4_161437776370492.xml","form_type":"4"}},{"id":2829172,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2021-02-26T22:16:39.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":18556,"source":{"system":"sec-edgar","filing":"0001367644-21-000045","document":"wf-form4_161437776370492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000045/wf-form4_161437776370492.xml","form_type":"4"}},{"id":2829171,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2021-02-26T22:16:39.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":3209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":18989,"source":{"system":"sec-edgar","filing":"0001367644-21-000045","document":"wf-form4_161437776370492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000045/wf-form4_161437776370492.xml","form_type":"4"}},{"id":2829170,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2021-02-26T22:16:39.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":3209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":15780,"source":{"system":"sec-edgar","filing":"0001367644-21-000045","document":"wf-form4_161437776370492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000045/wf-form4_161437776370492.xml","form_type":"4"}},{"id":3179554,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-04-09T00:19:35.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":7293,"price":60,"value":437580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company."}],"balance_after":31512,"derivative":{"exercise_price":30.63,"expiration_date":"2022-02-27","underlying":"Employee Stock Options (Right to Buy)","underlying_shares":7293},"source":{"system":"sec-edgar","filing":"0001367644-20-000033","document":"wf-form4_158639155760496.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000033/wf-form4_158639155760496.xml","form_type":"4"}},{"id":3179553,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-04-09T00:19:35.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":3135,"price":60,"value":188100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company."}],"balance_after":38805,"derivative":{"exercise_price":30.86,"expiration_date":"2021-02-28","underlying":"Employee Stock Options (Right to Buy)","underlying_shares":3135},"source":{"system":"sec-edgar","filing":"0001367644-20-000033","document":"wf-form4_158639155760496.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000033/wf-form4_158639155760496.xml","form_type":"4"}},{"id":3179552,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-04-09T00:19:35.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":7293,"price":60,"value":437580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk."}],"balance_after":12571,"source":{"system":"sec-edgar","filing":"0001367644-20-000033","document":"wf-form4_158639155760496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000033/wf-form4_158639155760496.xml","form_type":"4"}},{"id":3179551,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-04-09T00:19:35.000Z","date":"2020-04-06","kind":"exercise","acquired":true,"shares":7293,"price":30.63,"value":223384.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk."}],"balance_after":19864,"source":{"system":"sec-edgar","filing":"0001367644-20-000033","document":"wf-form4_158639155760496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000033/wf-form4_158639155760496.xml","form_type":"4"}},{"id":3179550,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-04-09T00:19:35.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":3135,"price":60,"value":188100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk."}],"balance_after":12571,"source":{"system":"sec-edgar","filing":"0001367644-20-000033","document":"wf-form4_158639155760496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000033/wf-form4_158639155760496.xml","form_type":"4"}},{"id":3179549,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-04-09T00:19:35.000Z","date":"2020-04-06","kind":"exercise","acquired":true,"shares":3135,"price":30.86,"value":96746.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk."}],"balance_after":15706,"source":{"system":"sec-edgar","filing":"0001367644-20-000033","document":"wf-form4_158639155760496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000033/wf-form4_158639155760496.xml","form_type":"4"}},{"id":3179548,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-04-09T00:19:35.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":5666,"price":60,"value":339960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":12571,"source":{"system":"sec-edgar","filing":"0001367644-20-000033","document":"wf-form4_158639155760496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000033/wf-form4_158639155760496.xml","form_type":"4"}},{"id":3243403,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-02-28T02:21:37.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":14648,"price":61.44,"value":899973.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":37668,"derivative":{"exercise_price":61.44,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":14648},"source":{"system":"sec-edgar","filing":"0001367644-20-000018","document":"wf-form4_158285647946534.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000018/wf-form4_158285647946534.xml","form_type":"4"}},{"id":3243402,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-02-28T02:21:37.000Z","date":"2020-02-27","kind":"tax_withholding","acquired":false,"shares":608,"price":58.42,"value":35519.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":19661,"source":{"system":"sec-edgar","filing":"0001367644-20-000018","document":"wf-form4_158285647946534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000018/wf-form4_158285647946534.xml","form_type":"4"}},{"id":3243401,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-02-28T02:21:37.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":277,"price":59.91,"value":16595.07,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":20269,"source":{"system":"sec-edgar","filing":"0001367644-20-000018","document":"wf-form4_158285647946534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000018/wf-form4_158285647946534.xml","form_type":"4"}},{"id":3243400,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-02-28T02:21:37.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":382,"price":59.91,"value":22885.62,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":20546,"source":{"system":"sec-edgar","filing":"0001367644-20-000018","document":"wf-form4_158285647946534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000018/wf-form4_158285647946534.xml","form_type":"4"}},{"id":3243399,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-02-28T02:21:37.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":3662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period."}],"balance_after":20928,"source":{"system":"sec-edgar","filing":"0001367644-20-000018","document":"wf-form4_158285647946534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000018/wf-form4_158285647946534.xml","form_type":"4"}},{"id":3243398,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":140663,"kind":"person","name":"Kirk Sean","position":1,"cik":"0001778426","reported_name":"Kirk Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Manufacturing & Tech Ops"}}],"security":"Common Stock","published_at":"2020-02-28T02:21:37.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":3662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":17266,"source":{"system":"sec-edgar","filing":"0001367644-20-000018","document":"wf-form4_158285647946534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000018/wf-form4_158285647946534.xml","form_type":"4"}}]}